Question 1

How do β2-adrenoceptor agonists relieve asthma symptoms?

Accepted Answer

β2-adrenoceptor agonists target β2-receptors on bronchial smooth muscle cells, inducing muscle relaxation and dilating airways. This action alleviates wheezing, shortness of breath, and chest tightness. The medications work by stimulating these receptors to facilitate easier breathing and restore normal airflow during asthma episodes.

Question 2

What is the difference between short-acting and long-acting β2-agonists?

Accepted Answer

Short-acting β2-agonists (SABAs) like albuterol and terbutaline provide immediate relief during acute asthma episodes by rapidly relaxing airway muscles. Long-acting β2-agonists (LABAs) such as salmeterol and formoterol sustain bronchodilation over extended periods, serving as preventive measures for chronic bronchial conditions to maintain open airways.

Question 3

Why are metered-dose inhalers and nebulizers preferred for administering β2-agonists?

Accepted Answer

Metered-dose inhalers and nebulizers deliver β2-agonists directly to the respiratory tract, ensuring rapid medication delivery to target airways. This direct administration maximizes therapeutic effectiveness while minimizing systemic exposure, allowing patients to experience faster symptom relief with lower overall drug exposure.

Question 4

What are the common adverse effects of β2-adrenoceptor agonists?

Accepted Answer

The most common adverse effect is tremor, resulting from β2-receptor stimulation in skeletal muscles. Other potential side effects include tachycardia (rapid heart rate) and cardiac dysrhythmias (irregular heart rhythms) from β2-receptor stimulation in the heart. These systemic effects occur because β2-adrenoceptors are present throughout the body, not just in airways.

Question 5

How do β2-agonists fit into comprehensive asthma management strategies?

Accepted Answer

β2-agonists are pivotal bronchodilators in asthma management, with SABAs providing acute symptom relief and LABAs offering chronic prevention. They work alongside other antiasthma drugs including inhaled corticosteroids and glucocorticoids to comprehensively control airway inflammation and constriction, requiring medical supervision to monitor effectiveness and adverse effects.

Question 6

What mechanism allows β2-agonists to work in both acute and chronic asthma?

Accepted Answer

SABAs rapidly penetrate airways and quickly relax bronchial muscles during acute episodes, providing immediate relief. LABAs maintain sustained bronchodilation through prolonged receptor stimulation, preventing airway constriction before it occurs. This dual mechanism—immediate versus sustained action—allows β2-agonists to address both emergency symptoms and long-term disease control.

Question 7

How does bronchial smooth muscle relaxation improve respiratory function in asthma?

Accepted Answer

When β2-agonists relax bronchial smooth muscle, the airways dilate, reducing resistance to airflow and restoring normal breathing patterns. This bronchial muscle relaxation directly counteracts the airway constriction characteristic of asthma, allowing air to flow freely through the respiratory tract and eliminating symptoms like wheezing and breathlessness.

Leki przeciwastmatyczne: Agonisty receptorów β_2-adrenergicznych

Browse More Videos